Pulmonary drug delivery of clofazimine: A route of administration and pharmacokinetics guided repositioning strategy against drug resistant tuberculosis informed by use for other disease indications
Authors:
- 12 August 2025
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (10) , 103952
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Solubilization techniques used for poorly water-soluble drugsActa Pharmaceutica Sinica B, 2024
- Engineering the right formulation for enhanced drug deliveryAdvanced Drug Delivery Reviews, 2022
- Solid state of inhalable high dose powdersAdvanced Drug Delivery Reviews, 2022
- Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approachesAdvanced Drug Delivery Reviews, 2022
- A Novel Case of Clofazimine-Induced Purple Nasal Mucosal DiscolorationJAMA Otolaryngology–Head & Neck Surgery, 2021
- Clofazimine-related duodenal pigmentationIndian Journal of Gastroenterology, 2021
- Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung DiseaseDrugs, 2019
- Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signalingBiochemical Pharmacology, 2014
- Shape Induced Inhibition of Phagocytosis of Polymer ParticlesPharmaceutical Research, 2008
- Particle Engineering for Pulmonary Drug DeliveryPharmaceutical Research, 2007